Vitalhub Corp T.VHI

Alternate Symbol(s): VHIBF

Healthcare Medical Devices

VitalHub Corp. is a software company. It offers software for health and human service providers designed to simplify the user experience and optimize outcomes. It offers a comprehensive suite of software-as-a-service solutions, which include electronic health record (EHR), case management, care coordination, and optimization; patient flow, operational visibility, and patient journey optimization; and workforce automation and compliance. Its solutions include Alamac, Beautiful Information, Hicom, Intouch with Health, MCAP, Oculys, SHREWD, Synopsis, B Care, CaseWORKS, Pirouette, S12 Solutions, OrderWise and TREAT. Its clients include hospitals, regional health authorities, mental health and addictions services providers for children and adults, long-term care facilities, correctional services, and community and social services providers. It also offers transitions of care technology internationally. It serves clients across Canada, the USA, the UK, Australia, the Middle East, and Europe.

TSX:VHI - Post by User

Vitalhub Corp

<< Previous

Bullboard Posts

Next >>

Post by Possibleidiot01on Nov 01, 2024 6:43pm

178 Views

Post# 36293152

Trevor Rose's Insights - PARTIAL BUY

PARTIAL BUY

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

VHI’s EBITDA margin has improved in recent quarters to 26% in Q2-2024 compared to last year’s 23%. EBITDA Margins have improved gradually due to a business model with highly favourable operational leverage, where most of the growth flows straight to the bottom line due to the limited capex required. The recent acquisition of Strata Health marks VHI’s largest acquisition ever. We have comments on the recent acquisition here.

VHI will fund the acquisition for a total up-front consideration of $32.3M through a combination of cash ($18.6M) and 1,480,726 shares. On the trailing twelve-month basis, Strata Health generated $12.7M in revenue and has an annual recurring revenue (ARR) of $12.3M, the deal is valued at 2.6x ARR. We think the deal is highly accretive to VHI as VHI itself is trading at around 10x ARR. We like the deal, we think VHI can continue to execute its acquisitive growth strategy in an efficient way going forward.
Unlock Premium - Try 5i Free

Healthcare

<< Previous

Bullboard Posts

Next >>

Three business reasons companies need to recycle e-waste